Pipeline

VetrixBio is advancing new therapies for osteoarthritis and cancer in pets—areas of high unmet need with limited treatment options, poor outcomes, and compelling commercial opportunity.

    Design

    Preclinical

 Clinical Studies

Pivotal Studies

VTX-304

Osteoarthritis

Clinical Studies

65%

VTX 301/302

Solid Tumors

Preclinical Studies

38%

Undisclosed

Expansion Indications

Design

20%